DEA Recordkeeping: The Audit-Ready Controlled Substance File

Every pharmacy registered with the Drug Enforcement Administration to handle controlled substances operates under a recordkeeping regime built to make diversion visible before it becomes a criminal matter. Under 21 CFR Part 1304, the ordering rules of 21 CFR Part 1305, and the loss reporting rules of 21 CFR 1301.76(b), a pharmacist-in-charge is responsible for a biennial physical inventory, complete DEA Form 222 or CSOS ordering records, and prompt notice of any theft or significant loss. A pharmacy that treats these obligations as routine paperwork until a DEA Diversion Investigator arrives is already behind. The gap between what the file shows and what is on the shelf is the starting point for most administrative actions against a pharmacy's registration.

The Biennial Inventory Requirement

Every registrant that handles controlled substances must take a complete physical inventory at least once every two years, on a date the registrant selects within that window, under 21 CFR § 1304.11. The counting method depends on the schedule involved. Schedule I and II substances require an exact count of every unit. Schedule III, IV, and V substances may be estimated unless a container holds more than 1,000 tablets or capsules, in which case an exact count is required. The inventory must be taken at the opening or close of business on the selected date, recorded in writing, and kept at the registered location for at least two years. A biennial inventory that is late, incomplete, or reconstructed after the fact is one of the first records a DEA investigator asks to see, and one of the easiest deficiencies to prove.

Form 222 and CSOS Ordering Records

Every acquisition of a Schedule I or II controlled substance must be documented on a DEA Form 222 or its electronic equivalent, the Controlled Substance Ordering System, under 21 CFR Part 1305. Electronic ordering is not mandatory. A pharmacy may continue to use paper Form 222s, but whichever method is used, the completed order records must be kept available for inspection for two years and must support accurate inventory reconciliation against what the pharmacy actually received and dispensed. When ordering records, invoices, and the physical count do not line up, the mismatch does not stay a bookkeeping problem. It becomes the evidentiary basis for a finding that controlled substances left the pharmacy through some route other than a lawful dispensing.

A closing count that does not match the ordering and dispensing record is not a paperwork lapse. It is the discrepancy DEA auditors build a diversion case around.

Reporting Theft and Significant Loss

When controlled substances go missing, the reporting clock starts immediately. Under a final rule that took effect July 24, 2023, a registrant must give the local DEA Diversion Field Division Office written preliminary notice of a theft or significant loss within one business day of discovering it, then complete and submit an accurate DEA Form 106 through DEA's secure online system within 45 days of discovery. Federal regulations do not define a significant loss by a fixed quantity or percentage. Whether a loss counts as significant depends on the substance, the quantity relative to the pharmacy's normal handling, and its overall pattern of loss, which means the determination itself can be second-guessed later even when the pharmacy files on time.

A pharmacy familiar with its rights during a records inspection, covered in DEA Inspections: A Pharmacy's Rights and Obligations, is better positioned when a loss report draws follow-up questions. In severe cases, recordkeeping failures combined with suspected ongoing diversion have supported DEA Immediate Suspension Orders: The Imminent Danger Standard, which remove a registration before any hearing.

Why Early Legal Counsel Is Critical

It is critical that pharmacies promptly retain healthcare defense counsel upon receiving notice of a DEA recordkeeping inspection finding, a biennial inventory discrepancy, or a theft or loss report that draws follow-up questions from a Diversion Investigator. Early legal intervention can protect the pharmacy's rights, ensure that responses to government requests are accurate and appropriately scoped, avoid inadvertent admissions during an inspection or interview, preserve relevant defenses, and allow counsel to communicate with investigators on the pharmacy's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the pharmacy to unnecessary risk, including an order to show cause or suspension of its registration.

How Health Law Alliance Can Help

Health Law Alliance defends pharmacies and pharmacists-in-charge through DEA recordkeeping inspections, biennial inventory disputes, and theft and loss reporting matters, from the first field office inquiry through any administrative hearing that follows. We review inventory and ordering records before DEA does, help clients correct and document discrepancies, and represent pharmacies in communications with the Diversion Field Division Office once an inquiry has started. If your pharmacy has received an inspection finding, an inventory discrepancy notice, or a records request tied to a theft or loss report, contact us for a free, confidential consultation.